A 12 Month, Long-term Follow-up Study of Patients With Actinic Keratosis on Non-head Locations (Trunk and Extremities) Who Have Completed Day 57 in Study PEP005-028 (REGION Ib)
Observational
Observational Model: Case-Only, Time Perspective: Prospective
Summarize treatment area recurrence of AK lesions, in the selected treatment area during a 12 month follow-up period for patients with complete clearance, who have completed Day 57 in Study PEP005-028.
12 months
Yes
United States: Food and Drug Administration
PEP005-032
NCT00989313
September 2009
October 2010
Name | Location |
---|---|
Virginia Clinical Research, Inc | Norfolk, Virginia 23507 |
Dawes Fretzin Clinical Research Group, LLC | Indianapolis, Indiana 46256 |
Dermatology Clinical Research Center of San Antonio | San Antonio, Texas 78229 |
DermResearch, Inc. | Austin, Texas 78759 |
Altman Dermatology Associates | Arlington Heights, Illinois 60004 |
Dermatology Associates of Tyler | Tyler, Texas 75703 |
Dermatology Research Centre | 3920 South 1100 East Suite 210 & 310 Salt Lake City, Utah 84124 |
Skin Surgery Medical Group Inc. | 5222 Balboa Avenue Sixth Floor, San Diego, California |
Glazer Dermatology | Buffalo Grove, Illinois 60089 |
Burke Pharmaceutical Research | Hot Springs, Arizona 71913 |
Skin Specialists, PC | Omaha, Nebraska |
Karl G. Heine Dermatology | Henderson, Nevada 89002 |
Suzanne Bruce and Associates, PA, The Center for Skin Research | Houston, Texas 77056 |
The Education and Research Foundation | Lynchburg, Virginia 24501 |
Atlanta Dermatology, Vein & Research Center, LLC | Alpharetta, Georgia 30022 |
Deaconess Clinic Downtown | Evansville, Indiana 47713 |
Group Health Associates | Cincinnati, Ohio 45220 |